ReachMD

Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

1595

LikeLikedUnlike

Episodes 1-15 of 243

- Carl C. Awh, MD
  Peer
- Peter A. Campochiaro, MD
  Peer
0
CME/CE
Am Horizont: Strategien für operativen Erfolg und dauerhafte Anti-VEGF-Therapie bei nAMD und DME
Am Horizont: Strategien für operativen Erfolg und dauerhafte Anti-VEGF-Therapie bei nAMD und DME
0.25 credits
- Clete A. Kushida, MD, PhD
  Peer
- Michael J. Thorpy, MD
  Peer
0
CME/CE
The Future of Narcolepsy Therapy: Its Likely Impact on Disease Burden and Patient Outcomes
The Future of Narcolepsy Therapy: Its Likely Impact on Disease Burden and Patient Outcomes
0.25 credits
- Carl C. Awh, MD
  Peer
- Peter A. Campochiaro, MD
  Peer
0
CME/CE
On the Horizon: Strategies for Surgical Success of Durable Anti-VEGF Delivery in nAMD and DME
On the Horizon: Strategies for Surgical Success of Durable Anti-VEGF Delivery in nAMD and DME
0.25 credits
- Joseph Saseen, PharmD, BCPS, BCACP, CLS
  Peer
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
0
CME/CE
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
0.25 credits
- Ezra Cohen, MD
  Peer
- Barbara Burtness, MD
  Peer
0
CME/CE
Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes
Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes
0.25 credits
- Carl C. Awh, MD
  Peer
- Peter A. Campochiaro, MD
  Peer
0
CME/CE
No horizonte: Estratégia para o sucesso cirúrgico da injeção Anti-VEGF em nAMD e DME
No horizonte: Estratégia para o sucesso cirúrgico da injeção Anti-VEGF em nAMD e DME
0.25 credits
- Diana Do, MD
  Peer
- Nancy M. Holekamp, MD
  Peer
- Carl Regillo, MD
  Peer
0
CME/CE
On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME
On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME
0.50 credits
- Diana Do, MD
  Peer
- Nancy M. Holekamp, MD
  Peer
- Carl Regillo, MD
  Peer
0
CME/CE
Am Horizont: Erreichen einer dauerhaften VEGF-Suppression bei nAMD und DME
Am Horizont: Erreichen einer dauerhaften VEGF-Suppression bei nAMD und DME
0.50 credits
- Cassandra B. Donnelly, DO
  Peer
- Charles P. Vega, MD
  Peer
0
CME/CE
Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis
Act Fast: A Case Study on Post-Exposure Influenza Prophylaxis
0.25 credits
- Diana Do, MD
  Peer
- Nancy M. Holekamp, MD
  Peer
- Carl Regillo, MD
  Peer
0
CME/CE
No horizonte: Alcançando a supressão duradoura de VEGF em DMRIn e EMD
No horizonte: Alcançando a supressão duradoura de VEGF em DMRIn e EMD
0.50 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Kenneth J. Moise, Jr., MD
  Peer
- Christopher Robinson, MD
  Peer
1
CME/CE
HDFN: New Understandings of Risk, Diagnosis, and Therapeutic Approaches
HDFN: New Understandings of Risk, Diagnosis, and Therapeutic Approaches
0.25 credits
- Kristi K. Orbaugh, MSN, NP, AOCN®
  Peer
- Val R. Adams, PharmD, FCCP, BCOP, FHOPA
  Peer
- Theresa W. Gillespie, PhD, MA, RN, FAAN
  Peer
0
CME/CE
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer
Advanced Practice Perspectives on CDK 4/6 Inhibitors: Paving the Way for HR+, HER2-Negative Early Breast Cancer
1.00 credits
- John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
  Peer
2
CME/CE
The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy
The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy
1.25 credits
- Erin D. Michos, MD, MHS, FACC, FAHA, FASE
  Peer
- Leslie Cho, MD
  Peer
1
CME/CE
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
0.25 credits
- Paul P. Doghramji, MD, FAAFP
  Peer
- Nina Delaney Wagner-Johnston, MD
  Peer
- Seema A. Bhat, MD
  Peer
0
CME/CE
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy
0.50 credits

Programs 8/2/21

Segment Chapters

Playlist:

Recommended